StockNews.AISignal intelligence
AirSculpt Technologies, Inc. · NASDAQ · Healthcare
Browse public AIRS signals with their source context and measured market impact. Open any signal for its permanent analysis page.
AIRS reported worse-than-expected Q3 and lowered FY25 revenue outlook. CEO cites progress on growth initiatives, margin improvement, and debt reduction. Shares fell ~60% month; closed $4.17 with RSI 29.3. 52-week low $1.53, indicating prior substantial downside and high volatility.
View signal analysis- AirSculpt Technologies reported $47.62 million in revenue, a 4% increase from the previous year. - EPS for the quarter was $0.03, down from $0.10 in the same period last year. - Revenue missed the Zacks Consensus Estimate by -4.88%. - Investors closely monitor year-over-year changes in revenue and EPS to gauge performance. - Key metrics like number of facilities and revenue per case were below analyst estimates. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
View signal analysis- AirSculpt Technologies quarterly earnings $0.03 per share, missed estimates by 62.50%. - Revenues for quarter ended March 2024 at $47.62 million, below expectations by 4.88%. - AirSculpt Technologies stock down 28% in 2024, underperforming the S&P 500. - Earnings outlook for AirSculpt is mixed with Zacks Rank #3 (Hold). - Bitfarms Ltd. in same industry, expected to report quarterly loss of $0.03 per share. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
View signal analysis